Literature DB >> 7877964

Kinetic and affinity limits on antibodies produced during immune responses.

J Foote1, H N Eisen.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7877964      PMCID： PMC42497          DOI： 10.1073/pnas.92.5.1254

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  31 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

2.  Avidin.

Authors:  N M Green
Journal:  Adv Protein Chem       Date:  1975

3.  Fluorescent probes for the study of the antibody-hapten reaction. II. Variation in te antibody combining site during the immune response.

Authors:  C W Parker; S M Godt; M C Johnson
Journal:  Biochemistry       Date:  1967-11       Impact factor: 3.162

Review 4.  Cell selection by antigen in the immune response.

Authors:  G W Siskind; B Benacerraf
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

5.  Variability in the lambda light chain sequences of mouse antibody.

Authors:  M G Weigert; I M Cesari; S J Yonkovich; M Cohn
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

6.  Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region.

Authors:  A L Bothwell; M Paskind; M Reth; T Imanishi-Kari; K Rajewsky; D Baltimore
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

7.  mRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification.

Authors:  M Kaartinen; G M Griffiths; A F Markham; C Milstein
Journal:  Nature       Date:  1983 Jul 28-Aug 3       Impact factor: 49.962

8.  IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts.

Authors:  P J Gearhart; N D Johnson; R Douglas; L Hood
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

9.  Antibody affinity. II. Effect of immunization interval on antihapten antibody in the rabbit.

Authors:  H Fujio; F Karush
Journal:  Biochemistry       Date:  1966-06       Impact factor: 3.162

10.  The relative affinity of antibodies synthesized in the secondary response.

Authors:  L A Steiner; H N Eisen
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307
View more
  91 in total

1.  In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

Authors:  P D Holler; P O Holman; E V Shusta; S O'Herrin; K D Wittrup; D M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Kinetics of association of anti-lysozyme monoclonal antibody D44.1 and hen-egg lysozyme.

Authors:  G Altobelli; S Subramaniam
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

3.  Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity.

Authors:  E T Boder; K S Midelfort; K D Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Use of fluorescence-detected sedimentation velocity to study high-affinity protein interactions.

Authors:  Sumit K Chaturvedi; Jia Ma; Huaying Zhao; Peter Schuck
Journal:  Nat Protoc       Date:  2017-08-03       Impact factor: 13.491

5.  Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides.

Authors:  W R Usinger; A H Lucas
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

6.  Basic problems of serological laboratory diagnosis.

Authors:  W Fierz
Journal:  Mol Biotechnol       Date:  1999-12-01       Impact factor: 2.695

7.  Structural mechanism for affinity maturation of an anti-lysozyme antibody.

Authors:  Ana Cauerhff; Fernando A Goldbaum; Bradford C Braden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

8.  Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display.

Authors:  Christian Votsmeier; Hanna Plittersdorf; Oliver Hesse; Andreas Scheidig; Michael Strerath; Uwe Gritzan; Klaus Pellengahr; Peter Scholz; Andrea Eicker; David Myszka; Wayne M Coco; Ulrich Haupts
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

Review 9.  Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors:  Frédéric Ducancel; Bruno H Muller
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

10.  Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.

Authors:  H J de Haard; B Kazemier; M J Koolen; L J Nijholt; R H Meloen; B van Gemen; H R Hoogenboom; J W Arends
Journal:  Clin Diagn Lab Immunol       Date:  1998-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.